Regimen of cisplatin, vinblastine, temozolomide, IL-2, and INFa-2b shows to be active and well tolerated
Pearls From the Diversity in Dermatology Conference
The Cutaneous Connection: A Reminder of Patient Impact
Derm In The News: May 12-18
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s Access
Photographer Behind AbbVie's Clearly Me Campaign for Amplifying Voices of Psoriasis Speaks to Advocacy, Awareness